Intermezzo Rouses Drug Category With $100 Million Push


Purdue Pharma is preparing for an event that has recently become rare in pharmaceuticals — a big-budget blitz for of a potential blockbuster drug.

No Responses to “Intermezzo Rouses Drug Category With $100 Million Push”

Post a Comment